[PBBANK] QoQ Annualized Quarter Result on 30-Jun-2014 [#2]

Announcement Date
24-Jul-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
30-Jun-2014 [#2]
Profit Trend
QoQ- 1.94%
YoY- 4.09%
View:
Show?
Annualized Quarter Result
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Revenue 18,401,212 16,860,071 16,441,981 16,014,956 15,793,508 15,264,300 15,127,502 13.96%
PBT 5,954,712 5,814,255 5,662,636 5,389,588 5,308,400 5,309,984 5,291,597 8.19%
Tax -1,217,904 -1,250,915 -1,266,637 -1,199,858 -1,200,268 -1,204,342 -1,197,502 1.13%
NP 4,736,808 4,563,340 4,395,998 4,189,730 4,108,132 4,105,642 4,094,094 10.21%
-
NP to SH 4,686,076 4,518,830 4,353,132 4,146,656 4,067,728 4,064,683 4,052,088 10.18%
-
Tax Rate 20.45% 21.51% 22.37% 22.26% 22.61% 22.68% 22.63% -
Total Cost 13,664,404 12,296,731 12,045,982 11,825,226 11,685,376 11,158,658 11,033,408 15.33%
-
Net Worth 28,091,211 28,024,793 25,887,612 21,432,326 20,387,314 20,424,279 19,274,851 28.57%
Dividend
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Div - 2,085,206 1,146,092 1,611,031 - 1,821,157 1,027,263 -
Div Payout % - 46.14% 26.33% 38.85% - 44.80% 25.35% -
Equity
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Net Worth 28,091,211 28,024,793 25,887,612 21,432,326 20,387,314 20,424,279 19,274,851 28.57%
NOSH 3,882,138 3,882,138 3,882,138 3,502,243 3,501,831 3,502,225 3,502,035 7.11%
Ratio Analysis
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
NP Margin 25.74% 27.07% 26.74% 26.16% 26.01% 26.90% 27.06% -
ROE 16.68% 16.12% 16.82% 19.35% 19.95% 19.90% 21.02% -
Per Share
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
RPS 476.53 436.62 439.95 457.28 451.01 435.85 431.96 6.77%
EPS 121.36 123.74 121.55 118.40 116.16 116.06 115.71 3.23%
DPS 0.00 54.00 30.67 46.00 0.00 52.00 29.33 -
NAPS 7.2747 7.2575 6.9269 6.1196 5.8219 5.8318 5.5039 20.45%
Adjusted Per Share Value based on latest NOSH - 3,502,639
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
RPS 94.80 86.86 84.71 82.51 81.36 78.64 77.93 13.96%
EPS 24.14 23.28 22.43 21.36 20.96 20.94 20.88 10.16%
DPS 0.00 10.74 5.90 8.30 0.00 9.38 5.29 -
NAPS 1.4472 1.4438 1.3337 1.1042 1.0503 1.0522 0.993 28.57%
Price Multiplier on Financial Quarter End Date
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Date 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 -
Price 18.88 18.30 18.90 19.58 19.16 19.40 17.74 -
P/RPS 3.96 4.19 4.30 4.28 4.25 4.45 4.11 -2.45%
P/EPS 15.56 15.64 16.23 16.54 16.49 16.72 15.33 0.99%
EY 6.43 6.39 6.16 6.05 6.06 5.98 6.52 -0.92%
DY 0.00 2.95 1.62 2.35 0.00 2.68 1.65 -
P/NAPS 2.60 2.52 2.73 3.20 3.29 3.33 3.22 -13.29%
Price Multiplier on Announcement Date
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Date 20/04/15 05/02/15 23/10/14 24/07/14 21/04/14 05/02/14 22/10/13 -
Price 19.60 18.44 18.62 20.00 20.20 19.06 18.50 -
P/RPS 4.11 4.22 4.23 4.37 4.48 4.37 4.28 -2.66%
P/EPS 16.15 15.76 15.99 16.89 17.39 16.42 15.99 0.66%
EY 6.19 6.35 6.26 5.92 5.75 6.09 6.25 -0.64%
DY 0.00 2.93 1.65 2.30 0.00 2.73 1.59 -
P/NAPS 2.69 2.54 2.69 3.27 3.47 3.27 3.36 -13.79%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment